Pasar al contenido principal

FROM CELULAR SENESCENCE TO CELL REPROGRAMMING IN LIVING ORGANISMS.

RYC-2013-14747

•
Nombre agencia financiadora Ministerio de Ciencia e Innovación
Acrónimo agencia financiadora MICINN
Programa Programa Estatal de Promoción del Talento y su Empleabilidad en I+D+i
Subprograma Subprograma Estatal de Incorporación
Convocatoria Ramón y Cajal
Año convocatoria 2013
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)
Identificador persistente http://dx.doi.org/10.13039/501100004837

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

TUNAR lncRNA encodes a microprotein that regulates neural differentiation and neurite formation by modulating calcium dynamics

  • Senís, Elena
  • Esgleas, Miriam
  • Najas Sales, Sònia, 1985-
  • Jiménez-Sábado, Verónica
  • Bertani, Camilla
  • Giménez-Alejandre, Marta
  • Escriche, Alba
  • Ruiz Orera, Jorge, 1988-
  • Hergueta-Redondo, Marta
  • Jiménez, Mireia
  • Giralt, Albert
  • Nuciforo, Paolo G.
  • Albà Soler, Mar
  • Peinado, Héctor
  • Toro, Daniel
  • Hove-Madsen, Leif
  • Götz, Magdalena
  • Abad, María
Long noncoding RNAs (lncRNAs) are regulatory molecules which have been traditionally considered as "non-coding". Strikingly, recent evidence has demonstrated that many non-coding regions, including lncRNAs, do in fact contain small-open reading frames that code for small proteins that have been called microproteins. Only a few of them have been characterized so far, but they display key functions in a wide variety of cellular processes. Here, we show that TUNAR lncRNA encodes an evolutionarily conserved microprotein expressed in the nervous system that we have named pTUNAR. pTUNAR deficiency in mouse embryonic stem cells improves their differentiation potential towards neural lineage both in vitro and in vivo. Conversely, pTUNAR overexpression impairs neuronal differentiation by reduced neurite formation in different model systems. At the subcellular level, pTUNAR is a transmembrane protein that localizes in the endoplasmic reticulum and interacts with the calcium transporter SERCA2. pTUNAR overexpression reduces cytoplasmatic calcium, consistent with a possible role of pTUNAR as an activator of SERCA2. Altogether, our results suggest that our newly discovered microprotein has an important role in neural differentiation and neurite formation through the regulation of intracellular calcium. From a more general point of view, our results provide a proof of concept of the role of lncRNAs-encoded microproteins in neural differentiation., Work in the Abad lab is supported by VHIO, Fero Foundation, La Caixa Foundation (HR18-00256), Asociación Española Contra el Cancer (AECC), Cellex Foundation, Mutua Madrileña Foundation and by grants from the Spanish Ministry of Science and Innovation (SAF2015-69413-R; RTI2018-102046-B-I00). M.A. was recipient of a Ramon y Cajal contract from the Spanish Ministry of Science and Innovation (RYC-2013-14747). E.S. was recipient of a AECC Postdoctoral Fellowship. L.H-M. also acknowledges funding from grants SAF2017-88019-C3-1R y PID2020-116927RB-C21 from the Spanish Government. MG is supported by the advanced ERC grant NeuroCentro and the German Research Foundation (SFB870; SPP2202; SPP2306; SYNERGY; TRR274). DT is supported by the Ramón y Cajal program (RYC-2017-23486/RTI2018-095580-A-I00). MMA acknowledges funding from the Spanish Ministry of Science and Innovation PGC2018-094091-B-I00 co-funded by FEDER.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

TUNAR lncRNA Encodes a Microprotein that Regulates Neural Differentiation and Neurite Formation by Modulating Calcium Dynamics

  • Senís, Elena
  • Esgleas, Miriam
  • Najas, Sònia
  • Jiménez-Sábado, Verónica
  • Bertani, Camilla
  • Giménez-Alejandre, Marta
  • Escriche, Alba
  • Ruiz-Orera, Jorge
  • Hergueta-Redondo, Marta
  • Jiménez, Mireia
  • Giralt, Albert
  • Nuciforo, Paolo
  • Albà, M. Mar
  • Peinado, Héctor
  • Toro, Daniel del
  • Hove-Madsen, Leif
  • Götz, Magdalena
  • Abad, María
Long noncoding RNAs (lncRNAs) are regulatory molecules which have been traditionally considered as “non-coding”. Strikingly, recent evidence has demonstrated that many non-coding regions, including lncRNAs, do in fact contain small-open reading frames that code for small proteins that have been called microproteins. Only a few of them have been characterized so far, but they display key functions in a wide variety of cellular processes. Here, we show that TUNAR lncRNA encodes an evolutionarily conserved microprotein expressed in the nervous system that we have named pTUNAR. pTUNAR deficiency in mouse embryonic stem cells improves their differentiation potential towards neural lineage both in vitro and in vivo. Conversely, pTUNAR overexpression impairs neuronal differentiation by reduced neurite formation in different model systems. At the subcellular level, pTUNAR is a transmembrane protein that localizes in the endoplasmic reticulum and interacts with the calcium transporter SERCA2. pTUNAR overexpression reduces cytoplasmatic calcium, consistent with a possible role of pTUNAR as an activator of SERCA2. Altogether, our results suggest that our newly discovered microprotein has an important role in neural differentiation and neurite formation through the regulation of intracellular calcium. From a more general point of view, our results provide a proof of concept of the role of lncRNAs-encoded microproteins in neural differentiation., Work in the Abad lab is supported by VHIO, Fero Foundation, La Caixa Foundation (HR18-00256), Asociación Española Contra el Cancer (AECC), Cellex Foundation, Mutua Madrileña Foundation and by grants from the Spanish Ministry of Science and Innovation (SAF2015-69413-R; RTI2018-102046-B-I00). M.A. was recipient of a Ramon y Cajal contract from the Spanish Ministry of Science and Innovation (RYC-2013-14747). E.S. was recipient of a AECC Postdoctoral Fellowship. L.H-M. also acknowledges funding from grants SAF2017-88019-C3-1R y PID2020-116927RB-C21 from the Spanish Government. MG is supported by the advanced ERC grant NeuroCentro and the German Research Foundation (SFB870; SPP2202; SPP2306; SYNERGY; TRR274). DT is supported by the Ramón y Cajal program (RYC-2017-23486/RTI2018-095580-A-I00). MMA acknowledges funding from the Spanish Ministry of Science and Innovation PGC2018-094091-B-I00 co-funded by FEDER.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation

  • Boix, Olga
  • Martínez, Marion
  • Vidal, Santiago
  • Giménez-Alejandre, Marta
  • Palenzuela, Lluís
  • Lorenzo-Sanz, Laura
  • Quevedo, Laura
  • Moscoso, Olivier
  • Ruiz-Orera, Jorge
  • Ximénez-Embún, Pilar
  • Ciriaco, Nikaoly
  • Nuciforo, Paolo
  • Stephan-Otto Attolini, Camille
  • Albà, M. Mar
  • Muñoz, Javier
  • Tian, Tian V.
  • Varela, Ignacio
  • Vivancos, Ana
  • Ramón y Cajal, S.
  • Muñoz, Purificación
  • Rivas, Carmen
  • Abad, M.
The human transcriptome contains thousands of small open reading frames (sORFs) that encode microproteins whose functions remain largely unexplored. Here, we show that TINCR lncRNA encodes pTINCR, an evolutionary conserved ubiquitin-like protein (UBL) expressed in many epithelia and upregulated upon differentiation and under cellular stress. By gain- and loss-of-function studies, we demonstrate that pTINCR is a key inducer of epithelial differentiation in vitro and in vivo. Interestingly, low expression of TINCR associates with worse prognosis in several epithelial cancers, and pTINCR overexpression reduces malignancy in patient-derived xenografts. At the molecular level, pTINCR binds to SUMO through its SUMO interacting motif (SIM) and to CDC42, a Rho-GTPase critical for actin cytoskeleton remodeling and epithelial differentiation. Moreover, pTINCR increases CDC42 SUMOylation and promotes its activation, triggering a pro-differentiation cascade. Our findings suggest that the microproteome is a source of new regulators of cell identity relevant for cancer., Work in the Abad lab is supported by VHIO, Fero Foundation, La Caixa Foundation, Asociación Española Contra el Cancer (AECC), La Mutua Foundation and by grants from the Spanish Ministry of Science and Innovation (SAF2015-69413-R; RTI2018-102046-B-I00). M.A. was recipient of a Ramón y Cajal contract from the Spanish Ministry of Science and Innovation (RYC-2013-14747). O.B. is recipient of a FPIAGAUR fellowship from Generalitat de Catalunya. We also acknowledge funding from grant PGC2018-094091-B-I00 from the Spanish Government., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

TUNAR lncRNA encodes a microprotein that regulates neural differentiation and neurite formation by modulating calcium dynamics

  • Senís, Elena
  • Esgleas, Miriam
  • Najas Sales, Sònia, 1985-
  • Jiménez-Sábado, Verónica
  • Bertani, Camilla
  • Giménez-Alejandre, Marta
  • Escriche, Alba
  • Ruiz Orera, Jorge, 1988-
  • Hergueta-Redondo, Marta
  • Jiménez, Mireia
  • Giralt, Albert
  • Nuciforo, Paolo G.
  • Albà Soler, Mar
  • Peinado, Héctor
  • Toro, Daniel
  • Hove-Madsen, Leif
  • Götz, Magdalena
  • Abad, María
Long noncoding RNAs (lncRNAs) are regulatory molecules which have been traditionally considered as "non-coding". Strikingly, recent evidence has demonstrated that many non-coding regions, including lncRNAs, do in fact contain small-open reading frames that code for small proteins that have been called microproteins. Only a few of them have been characterized so far, but they display key functions in a wide variety of cellular processes. Here, we show that TUNAR lncRNA encodes an evolutionarily conserved microprotein expressed in the nervous system that we have named pTUNAR. pTUNAR deficiency in mouse embryonic stem cells improves their differentiation potential towards neural lineage both in vitro and in vivo. Conversely, pTUNAR overexpression impairs neuronal differentiation by reduced neurite formation in different model systems. At the subcellular level, pTUNAR is a transmembrane protein that localizes in the endoplasmic reticulum and interacts with the calcium transporter SERCA2. pTUNAR overexpression reduces cytoplasmatic calcium, consistent with a possible role of pTUNAR as an activator of SERCA2. Altogether, our results suggest that our newly discovered microprotein has an important role in neural differentiation and neurite formation through the regulation of intracellular calcium. From a more general point of view, our results provide a proof of concept of the role of lncRNAs-encoded microproteins in neural differentiation., Work in the Abad lab is supported by VHIO, Fero Foundation, La Caixa Foundation (HR18-00256), Asociación Española Contra el Cancer (AECC), Cellex Foundation, Mutua Madrileña Foundation and by grants from the Spanish Ministry of Science and Innovation (SAF2015-69413-R; RTI2018-102046-B-I00). M.A. was recipient of a Ramon y Cajal contract from the Spanish Ministry of Science and Innovation (RYC-2013-14747). E.S. was recipient of a AECC Postdoctoral Fellowship. L.H-M. also acknowledges funding from grants SAF2017-88019-C3-1R y PID2020-116927RB-C21 from the Spanish Government. MG is supported by the advanced ERC grant NeuroCentro and the German Research Foundation (SFB870; SPP2202; SPP2306; SYNERGY; TRR274). DT is supported by the Ramón y Cajal program (RYC-2017-23486/RTI2018-095580-A-I00). MMA acknowledges funding from the Spanish Ministry of Science and Innovation PGC2018-094091-B-I00 co-funded by FEDER.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

  • Chaib, Selim
  • Lopez-Dominguez, Jose Alberto
  • Lalinde Gutiérrez, Marta
  • Prats, Neus
  • Marin Guillen, Ines
  • Boix Sánchez, Olga
  • Pérez Ramos, Sandra
  • Escorihuela Baez, Marta
  • Garcia-Garijo, Andrea
  • Abad, Maria
  • Gros, Alena
  • Arribas, Joaquin
Chemotherapy; Intratumoral senescent cells, Quimioterapia; Células senescentes intratumorales, Quimioteràpia; Cèl·lules senescents intratumorals, Chemotherapy often generates intratumoral senescent cancer cells that strongly modify the tumor microenvironment, favoring immunosuppression and tumor growth. We discovered, through an unbiased proteomics screen, that the immune checkpoint inhibitor programmed cell death 1 ligand 2 (PD-L2) is highly upregulated upon induction of senescence in different types of cancer cells. PD-L2 is not required for cells to undergo senescence, but it is critical for senescent cells to evade the immune system and persist intratumorally. Indeed, after chemotherapy, PD-L2-deficient senescent cancer cells are rapidly eliminated and tumors do not produce the senescence-associated chemokines CXCL1 and CXCL2. Accordingly, PD-L2-deficient pancreatic tumors fail to recruit myeloid-derived suppressor cells and undergo regression driven by CD8 T cells after chemotherapy. Finally, antibody-mediated blockade of PD-L2 strongly synergizes with chemotherapy causing remission of mammary tumors in mice. The combination of chemotherapy with anti-PD-L2 provides a therapeutic strategy that exploits vulnerabilities arising from therapy-induced senescence., We thank the IRB Core Facilities (Functional Genomics Core, Biostatistics/Bioinformatics and Histopathology), the Parc Científic de Barcelona Animal Facility and the University of Barcelona/Centros Científicos y Tecnológicos de la Universidad de Barcelona Flow Cytometry Facility for their contribution to this work. J.A.L-D. was supported by the Spanish Ministry of Science through a Juan de la Cierva-Incorporación fellowship and by the Asociación Española Contra el Cáncer (AECC) through an AECC Investigador fellowship. I.M. was funded by an FPI fellowship from the Spanish Ministry of Science. Work in the laboratory of M.S. was funded by the IRB and ‘la Caixa’ Foundation, and by grants from the Spanish Ministry of Science cofunded by the European Regional Development Fund (ERDF) (no. SAF2017-82613-R), European Research Council (no. ERC-2014-AdG/669622) and Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282). J.L.K., T.T. and S.C. were supported by the National Institutes of Health (grant nos. R37AG13925, R33AG61456, R01AG072301, R01AG61414, P01AG62413 and UH3AG56933), the Connor Fund, Robert J. and Theresa W. Ryan and the Noaber Foundation. A.G. received funding from the Spanish Ministry of Science cofunded by the ERDF (no. RTC-2017-6123-1), from the Instituto de Salud Carlos III (no. MS15/00058) and from CAIMI-II (grant no. 53/2021) supported by the BBVA Foundation. A.G.-G. was the recipient of a PERIS grant (no. SLT017/20/000131) from the Generalitat de Catalunya. The laboratory of M. Abad received funding from the Spanish Ministry of Science and Innovation (nos. RTI2018-102046-B-I00A and RTC-2017-6123-1) and the AECC (no. PRYCO211023SERR). M.A. was the recipient of a Ramón y Cajal contract from the Spanish Ministry of Science and Innovation (no. RYC-2013-14747). O.B. was the recipient of a FPIAGAUR fellowship from Generalitat de Catalunya. Work in the laboratory of J.A. is supported by the Breast Cancer Research Foundation (no. BCRF-21-008), Instituto de Salud Carlos III (project refs. AC15/00062, CB16/12/00449 and PI19/01181) and the European Commission (under the Framework of the ERA-NET TRANSCAN-2 initiative cofinanced by FEDER), AECC and Fundació La Caixa (no. HR22-00776).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

TUNAR lncRNA Encodes a Microprotein that Regulates Neural Differentiation and Neurite Formation by Modulating Calcium Dynamics

  • Senís, Elena
  • Esgleas, Miriam
  • Najas, Sonia
  • Jiménez-Sábado, Verónica|||0000-0001-7720-988X
  • Bertani, Camilla
  • Giménez-Alejandre, Marta
  • Escriche, Alba
  • Ruiz-Orera, Jorge|||0000-0002-8317-0034
  • Hergueta-Redondo, Marta
  • Jiménez, Mireia
  • Giralt, Albert
  • Nuciforo, Paolo|||0000-0003-1380-0990
  • Albà, M. Mar
  • Peinado, Héctor|||0000-0002-4256-3413
  • Toro, Daniel del
  • Madsen, Leif Hove|||0000-0001-5493-3998
  • Götz, Magdalena
  • Abad, María|||0000-0002-1462-2498
Long noncoding RNAs (lncRNAs) are regulatory molecules which have been traditionally considered as "non-coding". Strikingly, recent evidence has demonstrated that many non-coding regions, including lncRNAs, do in fact contain small-open reading frames that code for small proteins that have been called microproteins. Only a few of them have been characterized so far, but they display key functions in a wide variety of cellular processes. Here, we show that TUNAR lncRNA encodes an evolutionarily conserved microprotein expressed in the nervous system that we have named pTUNAR. pTUNAR deficiency in mouse embryonic stem cells improves their differentiation potential towards neural lineage both in vitro and in vivo. Conversely, pTUNAR overexpression impairs neuronal differentiation by reduced neurite formation in different model systems. At the subcellular level, pTUNAR is a transmembrane protein that localizes in the endoplasmic reticulum and interacts with the calcium transporter SERCA2. pTUNAR overexpression reduces cytoplasmatic calcium, consistent with a possible role of pTUNAR as an activator of SERCA2. Altogether, our results suggest that our newly discovered microprotein has an important role in neural differentiation and neurite formation through the regulation of intracellular calcium. From a more general point of view, our results provide a proof of concept of the role of lncRNAs-encoded microproteins in neural differentiation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation

  • Boix, Olga
  • Martínez, Marion|||0000-0002-8403-1941
  • Vidal, Santiago
  • Giménez-Alejandre, Marta
  • Palenzuela, Lluís
  • Lorenzo-Sanz, Laura|||0000-0001-6477-2163
  • Quevedo, Laura|||0000-0001-8902-5818
  • Moscoso, Olivier
  • Ruiz-Orera, Jorge|||0000-0002-8317-0034
  • Ximénez-Embún, Pilar|||0000-0002-2582-9443
  • Ciriaco, Nikaoly|||0000-0002-1151-554X
  • Nuciforo, Paolo|||0000-0003-1380-0990
  • Stephan-Otto Attolini, Camille|||0000-0001-8045-320X
  • Albà, M. Mar
  • Muñoz, Javier|||0000-0003-3288-3496
  • Tian, Tian|||0000-0002-9906-0980
  • Varela, Ignacio|||0000-0002-0969-506X
  • Vivancos, Ana|||0000-0003-2888-6512
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
  • Muñoz, Purificación|||0000-0002-3751-2099
  • Rivas Vázquez, Carmen|||0000-0002-0518-7199
  • Abad, María|||0000-0002-1462-2498
The human transcriptome contains thousands of small open reading frames (sORFs) that encode microproteins whose functions remain largely unexplored. Here, we show that TINCR lncRNA encodes pTINCR, an evolutionary conserved ubiquitin-like protein (UBL) expressed in many epithelia and upregulated upon differentiation and under cellular stress. By gain- and loss-of-function studies, we demonstrate that pTINCR is a key inducer of epithelial differentiation in vitro and in vivo. Interestingly, low expression of TINCR associates with worse prognosis in several epithelial cancers, and pTINCR overexpression reduces malignancy in patient-derived xenografts. At the molecular level, pTINCR binds to SUMO through its SUMO interacting motif (SIM) and to CDC42, a Rho-GTPase critical for actin cytoskeleton remodeling and epithelial differentiation. Moreover, pTINCR increases CDC42 SUMOylation and promotes its activation, triggering a pro-differentiation cascade. Our findings suggest that the microproteome is a source of new regulators of cell identity relevant for cancer. Small proteins encoded by previously assumed non-coding RNAs can have cell regulatory functions. Here the authors report that TINCR lncRNA encodes pTINCR, a ubiquitin-like protein (UBL) that promotes epithelial differentiation through the SUMOylation and activation of CDC42, and it has tumour suppressor activity in epithelial cancers.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

  • Chaib, Selim
  • Lopez-Dominguez, Jose Alberto
  • Lalinde Gutiérrez, Marta
  • Prats, Neus
  • Marin Guillen, Ines
  • Boix Sánchez, Olga
  • Pérez Ramos, Sandra
  • Escorihuela Baez, Marta
  • Garcia-Garijo, Andrea
  • Abad, Maria
  • Gros, Alena
  • Arribas, Joaquin
Chemotherapy; Intratumoral senescent cells, Quimioterapia; Células senescentes intratumorales, Quimioteràpia; Cèl·lules senescents intratumorals, Chemotherapy often generates intratumoral senescent cancer cells that strongly modify the tumor microenvironment, favoring immunosuppression and tumor growth. We discovered, through an unbiased proteomics screen, that the immune checkpoint inhibitor programmed cell death 1 ligand 2 (PD-L2) is highly upregulated upon induction of senescence in different types of cancer cells. PD-L2 is not required for cells to undergo senescence, but it is critical for senescent cells to evade the immune system and persist intratumorally. Indeed, after chemotherapy, PD-L2-deficient senescent cancer cells are rapidly eliminated and tumors do not produce the senescence-associated chemokines CXCL1 and CXCL2. Accordingly, PD-L2-deficient pancreatic tumors fail to recruit myeloid-derived suppressor cells and undergo regression driven by CD8 T cells after chemotherapy. Finally, antibody-mediated blockade of PD-L2 strongly synergizes with chemotherapy causing remission of mammary tumors in mice. The combination of chemotherapy with anti-PD-L2 provides a therapeutic strategy that exploits vulnerabilities arising from therapy-induced senescence., We thank the IRB Core Facilities (Functional Genomics Core, Biostatistics/Bioinformatics and Histopathology), the Parc Científic de Barcelona Animal Facility and the University of Barcelona/Centros Científicos y Tecnológicos de la Universidad de Barcelona Flow Cytometry Facility for their contribution to this work. J.A.L-D. was supported by the Spanish Ministry of Science through a Juan de la Cierva-Incorporación fellowship and by the Asociación Española Contra el Cáncer (AECC) through an AECC Investigador fellowship. I.M. was funded by an FPI fellowship from the Spanish Ministry of Science. Work in the laboratory of M.S. was funded by the IRB and ‘la Caixa’ Foundation, and by grants from the Spanish Ministry of Science cofunded by the European Regional Development Fund (ERDF) (no. SAF2017-82613-R), European Research Council (no. ERC-2014-AdG/669622) and Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282). J.L.K., T.T. and S.C. were supported by the National Institutes of Health (grant nos. R37AG13925, R33AG61456, R01AG072301, R01AG61414, P01AG62413 and UH3AG56933), the Connor Fund, Robert J. and Theresa W. Ryan and the Noaber Foundation. A.G. received funding from the Spanish Ministry of Science cofunded by the ERDF (no. RTC-2017-6123-1), from the Instituto de Salud Carlos III (no. MS15/00058) and from CAIMI-II (grant no. 53/2021) supported by the BBVA Foundation. A.G.-G. was the recipient of a PERIS grant (no. SLT017/20/000131) from the Generalitat de Catalunya. The laboratory of M. Abad received funding from the Spanish Ministry of Science and Innovation (nos. RTI2018-102046-B-I00A and RTC-2017-6123-1) and the AECC (no. PRYCO211023SERR). M.A. was the recipient of a Ramón y Cajal contract from the Spanish Ministry of Science and Innovation (no. RYC-2013-14747). O.B. was the recipient of a FPIAGAUR fellowship from Generalitat de Catalunya. Work in the laboratory of J.A. is supported by the Breast Cancer Research Foundation (no. BCRF-21-008), Instituto de Salud Carlos III (project refs. AC15/00062, CB16/12/00449 and PI19/01181) and the European Commission (under the Framework of the ERA-NET TRANSCAN-2 initiative cofinanced by FEDER), AECC and Fundació La Caixa (no. HR22-00776).